Daoyin Technique for Improving Exercise Endurance in IPF

Prior treatment

• Patients who have been participating in other clinical trials within 1 month before enrollment.

Other illness

• Patients with comorbidities such as chronic obstructive pulmonary disease, lung cancer, active pulmonary tuberculosis, bronchiectasis, pulmonary embolism, and other pulmonary diseases.
• Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina pectoris, acute myocardial infarction, cardiac function at grade 3 or above, stroke, cerebral hemorrhage, etc.).
• Patients with severe liver diseases (such as bleeding caused by liver cirrhosis, portal hypertension, and esophagogastric varices) and severe kidney diseases (dialysis, kidney transplantation, etc.).
• Patients with progressive neuromuscular diseases.
• Patients with unclear consciousness, dementia, and various mental illnesses.

Other

• Patients in the acute exacerbation phase of IPF.
• Patients with severe osteoarthropathy or osteoporosis, and those with unstable fractures.
• Pregnant or lactating women, and patients with a recent pregnancy plan.
• Patients who need long - term use of ventilators and those with unstable vital signs while bedridden.

• Patients who meet the diagnostic criteria for IPF;
• Those who can tolerate guided - technique training;
• Aged between 40 and 85 years old;
• Those who can independently or with the assistance of family members use devices such as smartphones and computers during home - based training;
• Those who voluntarily accept treatment and sign the informed consent form.